Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Asahi Kasei launches Kevzara in Japan

Feb. 5, 2018

Anika Therapeutics collaborates with University of Liverpool on MSC therapy for osteoarthritis

Feb. 2, 2018

Pfizer enrolling patients in phase II study of PF-06823859 in moderate to severe dermatomyositis

Feb. 2, 2018

AstraZeneca initiates phase IIa study of AZD-9567 in rheumatoid arthritis

Feb. 1, 2018

European Commission grants approval to Taltz for active psoriatic arthritis

Jan. 25, 2018

The University of Kentucky patents prostaglandin E synthase inhibitors

Jan. 22, 2018

Etanercept biosimilar approved in Japan

Jan. 22, 2018

FDA accepts Sandoz's BLA for adalimumab biosimilar

Jan. 16, 2018

KA34 to enter clinical testing for the treatment of osteoarthritis

Jan. 11, 2018

Galapagos reports topline results from phase Ib study of GLPG-1972 in osteoarthritis

Jan. 9, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...